Oasyschair Co., Ltd.
USPTO PatentsView assignee record - 15 granted patents across 2 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A47C (CHAIRS; SOFAS; Beds).
The verdict
According to USPTO PatentsView, Oasyschair ranks #18,968 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 2 technology areas.
- #18,968
- of 49,997 US assignees by volume
- 4th percentile
- by Innovation Score (16.5/100)
- 3.1
- avg claims per patent
- -93%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R18968 · Foreign Corporation #18,968 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 15 grants
- MID-PACK #18,968/49,997
- PHOTO-FINISH Oasis Medical
- CPC-NARROW A47C · 2 areas
- INNOV-LOW 16.5/100
- CLAIMS-SPARSE 3.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -93% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Oasis Medical, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Oasyschair’s 16.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Oasyschair
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Oasyschair · this assignee 16
Oasyschair · this assignee
16 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Oasyschair's Innovation Score is 16.5/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Oasyschair?
Each dot is one of Oasyschair’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oasyschair’s own 3.1 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Oasyschair's grants concentrate
Oasyschair Co., Ltd. is a focused PatentsView assignee: 2 CPC subclasses with 33.3% of grants classified under A47C (CHAIRS; SOFAS; Beds). Peak complete grant year is 2017 (8 grants) versus a trough of 1 in 2018. By volume, Oasyschair sits between Otsuka America Pharmaceutical, Inc. and OmniVision Sensor Solution (Shanghai) Co., Ltd.
Who files at Oasyschair's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Otsuka America Ph…
Otsuka America Pharmaceutical, Inc.
15 patents
- Oxis Energy
Oxis Energy Limited
15 patents
- Oxitec
Oxitec Ltd.
15 patents
- Oasis Medical
Oasis Medical, Inc.
15 patents
- Obeebo Labs
Obeebo Labs Ltd.
15 patents
- Odfjell Well Serv…
Odfjell Well Services Norway AS
15 patents
- Olix Pharmaceutic…
OliX Pharmaceuticals. Inc.
15 patents
- Omnivision Sensor…
OmniVision Sensor Solution (Shanghai) Co., Ltd
15 patents
- Oasyschair ◀
Oasyschair Co., Ltd.
15 patents
What this shows Oasyschair holds 15 patents at rank #18,973, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Oasyschair
By rank, the assignees closest to #18,973 in granted patent volume.
- Otsuka America Pharmaceutical, Inc. #18,969 · 15 patents
- Oxis Energy Limited #18,970 · 15 patents
- Oxitec Ltd. #18,971 · 15 patents
- Oasis Medical, Inc. #18,972 · 15 patents
- Obeebo Labs Ltd. #18,974 · 15 patents
- Odfjell Well Services Norway AS #18,975 · 15 patents
- OliX Pharmaceuticals. Inc. #18,976 · 15 patents
- OmniVision Sensor Solution (Shanghai) Co., Ltd #18,977 · 15 patents
Leaders in A47C (Chairs)
Other assignees with the most granted patents in Oasyschair's primary technology class.
Oasyschair's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
16 4th percentile higher than 4% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 20.0% |
| 2016 | 2 | 13.3% |
| 2017 | 8 | 53.3% |
| 2018 | 1 | 6.7% |
| 2021 | 1 | 6.7% |
Which technologies does Oasyschair Co., Ltd. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Oasyschair Co., Ltd.'s patent record in context - here's where to go next.
- Oasyschair Co., Ltd.'s lead technology class is A47C (CHAIRS; SOFAS; Beds), 33.3% of its portfolio - see every assignee active in that class. Explore A47C
- Ranked #18,968 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Oasyschair Co., Ltd. against Otsuka America Pharmaceutical, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 16.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.